Overall, ZQJ29 acts as a PARP1 inhibitor that downregulates the expression of SLC7A11 and GPX4 in a TP53‐dependent manner, thereby promoting ferroptosis in pancreatic cancer cells. The gene discussed is GPX4; the disease is pancreatic neoplasm.